Program availability

PSI offers assistance in a variety of diagnosis areas. Below is a list of our programs and the current program status. Please note that the list of available assistance is regularly updated. It may change as PSI adds services or support for newly funded programs. Likewise, the list may change as funding or support changes, or is no longer available for specific illnesses. Click here to learn more about our programs.

 

Idiopathic Pulmonary Fibrosis Program Now Accepting Applications.

bleeding disorders

Hemophilia (Bleeding Disorders)

  • Premium: This program is temporarily at 100% capacity. Please consider completing our inquiry form. The information submitted will help PSI make an appeal when requesting program funding for those living with a chronic illness. Please check back often as opportunities for  receiving financial assistance are updated daily.

Hemophilia-Bayer Co-pay/Co-Insurance Assistance Program

  • For inquiries regarding the Bayer Co-pay/Co-Insurance Assistance Program, please contact Bayer's Factor Solutions at 1-800-288-8374.

Inhibitors in Bleeding

  • Premium: This program is accepting new applications.

Novo Nordisk Hemophilia Copay Assistance Program

  • Copayment: This program is accepting new applications.

South Carolina State Bleeding Disorders Program

  • Premium: Please call us at 1-800-366-7741 for more information or to apply for assistance.

von Willebrand disease (Bleeding Disorders)

  • Premium: This program is temporarily at 100% capacity. Please consider completing our inquiry form. The information submitted will help PSI make an appeal when requesting program funding for those living with a chronic illness. Please check back often as opportunities for  receiving financial assistance are updated daily.

     

cancer

Breast Cancer Screening

  • Copayment: This program is accepting new applications.

Gastrointestinal Stromal Tumors

  • Copayment: This program is accepting new applications.

Opioid Therapy for Breakthrough Cancer Pain

  • Copayment: This program is accepting new applications.

Metastatic Melanoma/Metastatic Renal Cell Carcinoma

  • Incidental Expenses: This program is accepting new applications.
endocrine conditions

Fabry Disease

  • Copayment: This program is accepting new applications.
  • Premium: This program is accepting new applications.
  • Incidental Expenses: This program is accepting new applications.

Gaucher Disease

  • Copayment: This program is accepting new applications.

Mucopolysaccharidosis (MPS1)

  • Copayment: This program is accepting new applications.
  • Premium: This program is accepting new applications.
  • Incidental Expenses: This program is accepting new applications.

Pompe Disease

  • Copayment: This program is accepting new applications.
  • Premium: This program is accepting new applications.
  • Incidental Expenses: This program is accepting new applications.
genetic conditions

Homozygous Familial Hypercholesterolemia (HoFH)

  • Copayment: This program is accepting new applications.
  • Premium: This program is accepting new applications.
immunodeficiency conditions

Complement Mediated Diseases (CMD)

  • Copayment: This program is accepting new applications.
  • Premium: This program is accepting new applications.
  • Incidental Expenses: This program is accepting new applications.

Hereditary Angioedema

  • Copayment: This program is accepting new applications.
  • Premium: This program is accepting new applications.
  • Incidental Expenses: This program is accepting new applications.

Kidney Stones

  • Copayment: This program is accepting new applications.
  • Premium: This program is accepting new applications.

Primary Immune Deficiency

  • Premium: This program is accepting new applications.
  • Hizentra Copayment: For drug copayment assistance, please contact 877-355-IGIQ (4447).
  • Hizentra Ancillary Services: This program is accepting new applications.
  • Hizentra Premium: This program is accepting new applications.
leukemia and lymphoma

Chronic Myelogenous Leukemia (CML)

  • Copayment: This program is accepting new applications.
nervous system conditions

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

  • Premium: This program is accepting new applications.

Circadian Rhythm Disorders

  • Copayment: This program is accepting new applications.
  • Premium: This program is accepting new applications.

Pseudobulbar Affect

  • Copayment: This program is accepting new applications.
respiratory conditions

Alpha-1 Antitrypsin Deficiency

  • Copayment: This program is accepting new applications.
  • Premium: This program is accepting new applications.

Baxter Alpha-1 Antitrypsin Deficiency Copay/Co-insurance Assistance Program

  • Copayment: This program is accepting new applications.

Cystic Fibrosis

  • Copayment: This program is accepting new applications.

Idiopathic Pulmonary Fibrosis

  • Copayment: This program is accepting new applications.
  • Premium: This program is accepting new applications.
  • Incidental Expenses: This program is accepting new applications.